COVID-19 Updates
From the Journals
About 19% of COVID-19 headaches become chronic
News from the FDA/CDC
FDA to decide by June on future of COVID vaccines
“We’d love to see an annual vaccination similar to influenza but realize that the evolution of the virus will dictate how we respond in terms of...
Latest News
White House announces long-COVID action plan
The initiative will gather experts from various federal agencies to expand existing long-COVID clinics and broaden research on symptoms of the...
Latest News
New COVID combo-variant XE found in U.K.
A World Health Organization update notes XE’s high transmissibility and says it may have a growth advantage of 10%...
News from the FDA/CDC
Children and COVID-19: Decline in new cases may be leveling off
Small uptick in vaccine initiations was the first increase since early February.
From the Journals
First COVID-19 human challenge study provides insights
A small droplet that contains the coronavirus can infect someone with COVID-19, according to recent results from the first COVID-19 human...
From the Journals
Ivermectin doesn’t help treat COVID-19, large study finds
“Now that people can dive into the details and the data, hopefully that will steer the majority of doctors away from ivermectin toward other...
Livin' on the MDedge
Fingers take the fight to COVID-19
Plus: The interesting man in his flying machine, giving food as medicine some bite, and one benefit of being rude or stubborn.
News from the FDA/CDC
Children and COVID: The long goodbye continues
At its peak, the Omicron surge placed the highest burden on older Hispanic children.
News from the FDA/CDC
As FDA OKs another COVID booster, some experts question need
“Is the goal to prevent any symptomatic infection with COVID-19, is the goal to prevent the spread of COVID-19, or is the goal to prevent severe...
Conference Coverage
Aluminum named allergen of the year
Reactions normally present as itchy nodules that can last for months and even years.